欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号NL/H/2979/001
药品名称Regiocit
活性成分
    • sodium citrate 18.0 mmol/l
    • sodium chloride 140.0 mmol/l
剂型Solution for haemofiltration
上市许可持有人GAMBRO Lundia AB Magistratsvägen 16 S-22010 Lund Sweden
参考成员国 - 产品名称Netherlands (NL)
Prismocit
互认成员国 - 产品名称
    • Slovenia (SI)
    • Belgium (BE)
    • Malta (MT)
    • Luxembourg (LU)
    • Croatia (HR)
    • Iceland (IS)
    • United Kingdom (Northern Ireland) (XI)
    • Ireland (IE)
    • Austria (AT)
    • France (FR)
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Greece (GR)
    • Sweden (SE)
    • Norway (NO)
    • Finland (FI)
    • Poland (PL)
    • Latvia (LV)
    • Lithuania (LT)
    • Estonia (EE)
    • Hungary (HU)
    • Bulgaria (BG)
    • Cyprus (CY)
    • Czechia (CZ)
    • Romania (RO)
    • Germany (DE)
    • Slovakia (SK)
    • Denmark (DK)
许可日期2014/10/01
最近更新日期2023/11/15
药物ATC编码
    • B05ZB Hemofiltrates
申请类型
  • TypeLevel1：Known Active Substance
  • TypeLevel2：Initial Application
  • TypeLevel3：Bibliographic Art 10 a Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase